GlassScriptPhysician profile
Carl D Robinson
NPI 1639103997
$3,108.71
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $567 · 2021: $659 · 2022: $725 · 2023: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $638.96 | 2021-2023 | Ubrelvy, Qulipta |
| Allergan, INC. | $301.46 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $250.54 | 2019-2023 | |
| Biogen, INC. | $229.65 | 2019-2023 | Tysabri, Vumerity, Avonex |
| Emd Serono, INC. | $180.88 | 2020-2023 | Mavenclad |
| Sunovion Pharmaceuticals INC. | $169.71 | 2019-2021 | |
| Lilly USA, LLC | $146.97 | 2019-2021 | |
| Genzyme Corporation | $127.68 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $108.83 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $108.48 | 2019-2022 | |
| Amgen INC. | $97.72 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $85.17 | 2019-2022 | |
| Sk Life Science, INC. | $77.42 | 2020-2022 | |
| Genentech USA, INC. | $76.78 | 2019-2020 | |
| Acorda Therapeutics, INC | $66.05 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $60.84 | 2019 | |
| Mallinckrodt Enterprises LLC | $54.57 | 2019 | |
| Supernus Pharmaceuticals, INC. | $48.01 | 2019-2020 | |
| Grifols USA, LLC | $43.78 | 2020 | |
| Greenwich Biosciences, INC. | $39.99 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.00 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $25.86 | 2021 | |
| Tg Therapeutics, INC. | $24.30 | 2023 | |
| Livanova USA, INC. | $23.20 | 2019 | |
| Pfizer INC. | $17.41 | 2023 | |
| Avion Pharmaceuticals | $15.90 | 2022 | |
| Horizon Therapeutics Plc | $15.88 | 2022 | |
| Tanabe Pharma America, INC. | $15.71 | 2019 | |
| Csl Behring | $13.82 | 2019 | |
| Impel Pharmaceuticals INC. | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.